Miraca Life Sciences expands therapeutic drug monitoring service includes Simponi: 4 key notes

Irving, Texas-based Miraca Life Sciences expanded its InformTx therapeutic drug monitoring program to include Simponi and patient-developed antibodies to Simponi.

Advertisement

Here’s what you should know.

1. Miraca also performs monitoring for six biologic drugs used in inflammatory bowel disease treatments.

2. Simponi manages inflammatory bowel disease.

3. Miraca is the only therapeutic drug monitoring testing service for IBD patients.

4. InformTx reports include quantitative test results, historical test result data and advisory guidance based on peer-reviewed scientific literature.

More articles on gastroenterology:
Scientists on brink of identifying irritable bowel syndrome’s cause: 4 study insights
Replaced Olympus duodenoscopes tied to new bacterial outbreak in overseas facility: 6 key notes
Colorectal cancer rates rocketing in millennials — 5 study insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.